Biology Reference
In-Depth Information
hypoxic-ischemic brain damage. Acta Paediatr
Suppl 91:36-42
31. McPherson RJ, Juul SE (2008) Recent trends
in erythropoietin-mediated neuroprotection.
Int J Dev Neurosci 26:103-111
32. Xiong T, Qu Y, Mu D, Ferriero D (2011)
Erythropoietin for neonatal brain injury:
opportunity and challenge. Int J Dev Neurosci
29(6):583-591
33. Wang L, Zhang Z, Wang Y, Zhang R, Chopp
M (2004) Treatment of stroke with erythro-
poietin enhances neurogenesis and angiogen-
esis and improves neurological function in rats.
Stroke 35:1732-1737
34. Wallach I, Zhang J, Hartmann A, van
Landeghem FK, Ivanova A, Klar M, Dame C
(2009) Erythropoietin-receptor gene regula-
tion in neuronal cells. Pediatr Res 65:619-624
35. Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki
H, Asou H (2002) Effects of erythropoietin
on glial cell development; oligodendrocyte
maturation and astrocyte proliferation.
Neurosci Res 44:391-403
36. Nagai A, Nakagawa E, Choi HB, Hatori K,
Kobayashi S, Kim SU (2001) Erythropoietin
and erythropoietin receptors in human CNS
neurons, astrocytes, microglia, and oligoden-
drocytes grown in culture. J Neuropathol Exp
Neurol 60:386-392
37. Chong ZZ, Kang JQ, Maiese K (2003)
Erythropoietin fosters both intrinsic and extrin-
sic neuronal protection through modulation of
microglia, Akt1, Bad, and caspase-mediated
pathways. Br J Pharmacol 138:1107-1118
38. Digicaylioglu M, Lipton SA (2001)
Erythropoietin-mediated neuroprotection
involves cross-talk between Jak2 and NF-kappaB
signalling cascades. Nature 412:641-647
39. Genc K, Genc S, Baskin H, Semin I (2006)
Erythropoietin decreases cytotoxicity and
nitric oxide formation induced by inflammatory
stimuli in rat oligodendrocytes. Physiol Res
55:33-38
40. Vitellaro-Zuccarello L, Mazzetti S, Madaschi
L, Bosisio P, Fontana E, Gorio A, De Biasi S
(2008) Chronic erythropoietin-mediated
effects on the expression of astrocyte markers
in a rat model of contusive spinal cord injury.
Neuroscience 151:452-466
41. Dzietko M, Felderhoff-Mueser U, Sifringer
M, Krutz B, Bittigau P, Thor F, Heumann R,
Buhrer C, Ikonomidou C, Hansen HH (2004)
Erythropoietin protects the developing brain
against N-methyl-d-aspartate receptor antago-
nist neurotoxicity. Neurobiol Dis 15:177-187
42. Wang L, Chopp M, Gregg SR, Zhang RL,
Teng H, Jiang A, Feng Y, Zhang ZG (2008)
Neural progenitor cells treated with EPO
induce angiogenesis through the production
of VEGF. J Cereb Blood Flow Metab
28:1361-1368
43. Bocker-Meffert S, Rosenstiel P, Rohl C,
Warneke N, Held-Feindt J, Sievers J, Lucius R
(2002) Erythropoietin and VEGF promote
neural outgrowth from retinal explants in post-
natal rats. Invest Ophthalmol Vis Sci
43:2021-2026
44. Wang KK, Larner SF, Robinson G, Hayes RL
(2006) Neuroprotection targets after traumatic
brain injury. Curr Opin Neurol 19:514-519
45. Xiong Y, Mahmood A, Lu D, Qu C, Kazmi H,
Goussev A, Zhang ZG, Noguchi CT, Schallert
T, Chopp M (2008) Histological and functional
outcomes after traumatic brain injury in mice
null for the erythropoietin receptor in the cen-
tral nervous system. Brain Res 1230:247-257
46. Juul SE, McPherson RJ, Farrell FX, Jolliffe L,
Ness DJ, Gleason CA (2004) Erytropoietin
concentrations in cerebrospinal fluid of non-
human primates and fetal sheep following
high-dose recombinant erythropoietin. Biol
Neonate 85:138-144
47. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia
L, Ji L, Guo X, Xiong H, Simbruner G,
Blomgren K, Wang X (2009) Erythropoietin
improved neurologic outcomes in newborns
with
hypoxic-ischemic
encephalopathy.
Pediatrics 124:e218-e226
48. Kellert BA, McPherson RJ, Juul SE (2007) A
comparison of high-dose recombinant eryth-
ropoietin treatment regimens in brain-injured
neonatal rats. Pediatr Res 61:451-455
49. Gonzalez FF, Abel R, Almli CR, Mu D,
Wendland M, Ferriero DM (2009)
Erythropoietin sustains cognitive function and
brain volume after neonatal stroke. Dev
Neurosci 31:403-411
50. Juul SE, McPherson RJ, Bammler TK,
Wilkerson J, Beyer RP, Farin FM (2008)
Recombinant erythropoietin is neuroprotec-
tive in a novel mouse oxidative injury model.
Dev Neurosci 30:231-242
51. Tsai PT, Ohab JJ, Kertesz N, Groszer M,
Matter C, Gao J, Liu X, Wu H, Carmichael ST
(2006) A critical role of erythropoietin recep-
tor in neurogenesis and post-stroke recovery. J
Neurosci 26:1269-1274
52. Weber A, Dzietko M, Berns M, Felderhoff-
Mueser U, Heinemann U, Maier RF, Obladen
M, Ikonomidou C, Buhrer C (2005)
Neuronal damage after moderate hypoxia
and erythropoietin. Neurobiol Dis 20:
594-600
53. Juul SE, McPherson RJ, Bauer LA, Ledbetter
KJ, Gleason CA, Mayock DE (2008) A phase
I/II trial of high-dose erythropoietin in
extremely low birth weight infants: pharma-
cokinetics and safety. Pediatrics 122:383-391
Search WWH ::
Custom Search